Literature DB >> 24300480

Autophagy-mediated regulation of macrophages and its applications for cancer.

Peiwen Chen1, Matilde Cescon1, Paolo Bonaldo1.   

Abstract

Autophagy is a highly conserved homeostatic pathway that plays an important role in tumor development and progression by acting on cancer cells in a cell-autonomous mechanism. However, the solid tumor is not an island, but rather an ensemble performance that includes nonmalignant stromal cells, such as macrophages. A growing body of evidence indicates that autophagy is a key component of the innate immune response. In this review, we discuss the role of autophagy in the control of macrophage production at different stages (including hematopoietic stem cell maintenance, monocyte/macrophage migration, and monocyte differentiation into macrophages) and polarization and discuss how modulating autophagy in tumor-associated macrophages (TAMs) may represent a promising strategy for limiting cancer growth and progression.

Entities:  

Keywords:  autophagy; cancer; macrophage polarization; macrophage production; tumor-associated macrophages

Mesh:

Year:  2013        PMID: 24300480      PMCID: PMC5396097          DOI: 10.4161/auto.26927

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  80 in total

Review 1.  Control of infection by pyroptosis and autophagy: role of TLR and NLR.

Authors:  Karina R Bortoluci; Ruslan Medzhitov
Journal:  Cell Mol Life Sci       Date:  2010-03-13       Impact factor: 9.261

2.  HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.

Authors:  Charlotte Rolny; Massimiliano Mazzone; Sònia Tugues; Damya Laoui; Irja Johansson; Cathy Coulon; Mario Leonardo Squadrito; Inmaculada Segura; Xiujuan Li; Ellen Knevels; Sandra Costa; Stefan Vinckier; Tom Dresselaer; Peter Åkerud; Maria De Mol; Henriikka Salomäki; Mia Phillipson; Sabine Wyns; Erik Larsson; Ian Buysschaert; Johan Botling; Uwe Himmelreich; Jo A Van Ginderachter; Michele De Palma; Mieke Dewerchin; Lena Claesson-Welsh; Peter Carmeliet
Journal:  Cancer Cell       Date:  2011-01-06       Impact factor: 31.743

Review 3.  Autophagy and aging.

Authors:  David C Rubinsztein; Guillermo Mariño; Guido Kroemer
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

4.  Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice.

Authors:  Michael G Kharas; Rachel Okabe; Jared J Ganis; Maricel Gozo; Tulasi Khandan; Mahnaz Paktinat; D Gary Gilliland; Kira Gritsman
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

Review 5.  MicroRNA-mediated control of macrophages and its implications for cancer.

Authors:  Mario Leonardo Squadrito; Martin Etzrodt; Michele De Palma; Mikael J Pittet
Journal:  Trends Immunol       Date:  2013-03-13       Impact factor: 16.687

6.  A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche.

Authors:  Yoon-Young Jang; Saul J Sharkis
Journal:  Blood       Date:  2007-06-26       Impact factor: 22.113

7.  Toll-like receptor 4 is a sensor for autophagy associated with innate immunity.

Authors:  Yi Xu; Chinnaswamy Jagannath; Xian-De Liu; Amir Sharafkhaneh; Katarzyna E Kolodziejska; N Tony Eissa
Journal:  Immunity       Date:  2007-07-19       Impact factor: 31.745

8.  Identification of a candidate therapeutic autophagy-inducing peptide.

Authors:  Sanae Shoji-Kawata; Rhea Sumpter; Matthew Leveno; Grant R Campbell; Zhongju Zou; Lisa Kinch; Angela D Wilkins; Qihua Sun; Kathrin Pallauf; Donna MacDuff; Carlos Huerta; Herbert W Virgin; J Bernd Helms; Ruud Eerland; Sharon A Tooze; Ramnik Xavier; Deborah J Lenschow; Ai Yamamoto; David King; Olivier Lichtarge; Nick V Grishin; Stephen A Spector; Dora V Kaloyanova; Beth Levine
Journal:  Nature       Date:  2013-01-30       Impact factor: 49.962

9.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors:  John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

10.  Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.

Authors:  Heng Lin; Jun Yan; Ziyan Wang; Fang Hua; Jiaojiao Yu; Wei Sun; Ke Li; Hong Liu; Hongzhen Yang; Qi Lv; Jianfei Xue; Zhuo-Wei Hu
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

View more
  73 in total

1.  M1 and M2 Macrophages Polarization via mTORC1 Influences Innate Immunity and Outcome of Ehrlichia Infection.

Authors:  Ibrahim Ahmed; Nahed Ismail
Journal:  J Cell Immunol       Date:  2020

2.  Downregulation of calponin 2 contributes to the quiescence of lung macrophages.

Authors:  Olesya Plazyo; Juan-Juan Sheng; J-P Jin
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

Review 3.  Autophagy regulates insulin resistance following endoplasmic reticulum stress in diabetes.

Authors:  Ning Zhang; Ming-ming Cao; Han Liu; Guang-ying Xie; Yan-bo Li
Journal:  J Physiol Biochem       Date:  2015-01-30       Impact factor: 4.158

4.  LRRK2 but not ATG16L1 is associated with Paneth cell defect in Japanese Crohn's disease patients.

Authors:  Ta-Chiang Liu; Takeo Naito; Zhenqiu Liu; Kelli L VanDussen; Talin Haritunians; Dalin Li; Katsuya Endo; Yosuke Kawai; Masao Nagasaki; Yoshitaka Kinouchi; Dermot Pb McGovern; Tooru Shimosegawa; Yoichi Kakuta; Thaddeus S Stappenbeck
Journal:  JCI Insight       Date:  2017-03-23

5.  miR-125b controls monocyte adaptation to inflammation through mitochondrial metabolism and dynamics.

Authors:  Isabelle Duroux-Richard; Christine Roubert; Meryem Ammari; Jessy Présumey; Joachim R Grün; Thomas Häupl; Andreas Grützkau; Charles-Henri Lecellier; Valérie Boitez; Patrice Codogno; Johanna Escoubet; Yves-Marie Pers; Christian Jorgensen; Florence Apparailly
Journal:  Blood       Date:  2016-10-04       Impact factor: 22.113

6.  Multidrug Analyses in Patients Distinguish Efficacious Cancer Agents Based on Both Tumor Cell Killing and Immunomodulation.

Authors:  Jason P Frazier; Jessica A Bertout; William S Kerwin; Alicia Moreno-Gonzalez; Joey R Casalini; Marc O Grenley; Emily Beirne; Kori L Watts; Andy Keener; Derek J Thirstrup; Ilona Tretyak; Sally H Ditzler; Chelsea D Tripp; Kevin Choy; Sarah Gillings; Megan N Breit; Karri A Meleo; Vanessa Rizzo; Chamisa L Herrera; James A Perry; Ravi K Amaravadi; James M Olson; Richard A Klinghoffer
Journal:  Cancer Res       Date:  2017-03-31       Impact factor: 12.701

7.  The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML.

Authors:  Sandrine Obba; Zoheir Hizir; Laurent Boyer; Dorothée Selimoglu-Buet; Anja Pfeifer; Gregory Michel; Mohamed-Amine Hamouda; Diogo Gonçalvès; Michael Cerezo; Sandrine Marchetti; Stephane Rocchi; Nathalie Droin; Thomas Cluzeau; Guillaume Robert; Frederic Luciano; Bernard Robaye; Marc Foretz; Benoit Viollet; Laurence Legros; Eric Solary; Patrick Auberger; Arnaud Jacquel
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 8.  Combined strategies for tumor immunotherapy with nanoparticles.

Authors:  K Savitsky; X Yu
Journal:  Clin Transl Oncol       Date:  2019-05-04       Impact factor: 3.405

9.  Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation.

Authors:  Paul Zarogoulidis; Savvas Petanidis; Kalliopi Domvri; Efrosini Kioseoglou; Doxakis Anestakis; Lutz Freitag; Konstantinos Zarogoulidis; Wolfgang Hohenforst-Schmidt; Wilfried Eberhardt
Journal:  Mol Oncol       Date:  2016-09-16       Impact factor: 6.603

10.  Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells.

Authors:  Ting Li; Xiao-huang Xu; Zheng-hai Tang; Ya-fang Wang; Chung-hang Leung; Dik-lung Ma; Xiu-ping Chen; Yi-tao Wang; Yi Chen; Jin-jian Lu
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.